Velico Medical Announces A Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma

    Velico Medical Announces a Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma.   BARDA has extended its Spray Dried Plasma development contract with Velico Medical through November 2019 providing for an additional $18.9 million. This non-dilutive funding is expected to support the company’s development program through FDA approval to commence Phase I clinical trials.  Spray dried plasma is being developed as an alternative to frozen plasma and is expected to play a life-saving role wherever time to plasma transfusion is Continue reading →

Velico Medical Hires Internationally Recognized Transfusion Medicine Expert Mark Popovsky, M.D

BEVERLY, MASSACHUSETTS (PRWEB) SEPTEMBER 29, 2015 Velico Medical, Inc., a private, pre-clinical medical technology company developing breakthrough technologies to improve the quality, availability and economics of platelet and plasma transfusions, today announced that it has retained Mark Popovsky, M.D., as its Chief Medical Officer. Dr. Popovsky, an internationally renowned expert in the field of transfusion medicine, recently retired as Vice President and Chief Medical Officer of Haemonetics Corporation, a leading global blood products company. Dr. Popovsky will initially focus his efforts on accelerating Velico’s spray Continue reading →

Velico Medical Announces BARDA Exercise of $15.5 Million Contract Option

BEVERLY, MASSACHUSETTS (PRWEB) SEPTEMBER 09, 2015 Velico Medical today announced that the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA), has exercised its first option under its contract with Velico to further develop Velico’s Spray Dried Plasma technology (SpDP™). BARDA’s exercise of this option extends the contract through March 2017 and provides for up to approximately $15.5 million of additional funding to support the development of a system for spray drying plasma for transfusion. Spray dried plasma is being developed Continue reading →

Biomedical Advanced Research and Development Authority (BARDA)

Dried Plasma Device for CBRNE Mass Casualty Scenario OCTOBER 12, 2012 The Biomedical Advanced Research and Development Authority (BARDA) has awarded Velico Medical, Inc., a development contract worth up to $38.6 million for a device that could revolutionize emergency blood storage and shipment for use in chemical, biological, radiological, nuclear or high-yield explosive (CBRNE) or natural disaster emergencies. The spray-dry device would convert fresh liquid blood plasma into a sterile powder for more effective shipment and storage.  Current practices of utilizing frozen plasma pose logistical Continue reading →

OrbiMed Backs Velico Medical

Sells Rights to Receive Royalties to Major Institutional Investor SEPTEMBER 15, 2010 BY MASSDEVICE STAFF LEAVE A COMMENT Velico Medical Inc. sold some of its royalty rights to OrbiMed Advisors LLC for an unspecified amount. CFO Tom Fitzgerald told that the Beverly, Mass.-based firm plans to use the cash to shift its focus from developing its flagship “universal blood” technology to a pair of technologies it thinks it can bring to market faster. “We’re planning to use the proceeds to advance our near-term clinical programs for spray-dried plasma and Continue reading →